Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autoimmunity in Inner Ear Disease
NCT00000361Phase 3Terminated
- Sponsor
- National Institute on Deafness and Other Communication Disorders
- Start
- Mar 1998
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of prednisone, methotrexate, cyclophosphamide in autoimmune inner ear disease (AIED), sponsored by National Institute on Deafness and Other Communication Disorders. Started Mar 1998; status: terminated.
02
Drugs
prednisonemethotrexatecyclophosphamide
03
Conditions
autoimmune inner ear disease (AIED)
Beyond the preview
Go deeper on NCT00000361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000361.